TTOO / T2 Biosystems Secures Additional BARDA Funding To Develop Blood Test Panels To Detect Sepsis-Causing Pathogens

T2 Biosystems (NASDAQ: TTOO ) stock is in the green after the medical diagnostics company announced that it had received written notice from the Nasda more_horizontal

T2 Biosystems (NASDAQ: TTOO ) stock is plummeting lower following the company's announcement of a 1-for-100 reverse stock split and its preliminary th more_horizontal

T2 Biosystems makes medical diagnostic testing equipment. The company reported a likely 60% in revenue in a preliminary third-quarter earnings report. more_horizontal

T2 Biosystems, Inc. (NASDAQ:TTOO ) Preliminary Q3 2023 Earnings Call Transcript October 12, 2023 4:30 PM ET Company Participants Trip Taylor - IR John more_horizontal

Shares of T2 Biosystems (NASDAQ: TTOO ) are cratering lower today. This comes after the in vitro diagnostics company announced that its board of direc more_horizontal

T2 Biosystems (NASDAQ: TTOO ) announced today that it would report its preliminary quarterly earnings and provide business updates after the market cl more_horizontal

Another day, another sale of T2 Biosystems (NASDAQ: TTOO ) for 10% owner CR Group (CRG). Since Sept. more_horizontal

Shares of T2 Biosystems (NASDAQ: TTOO ) are up by over 20% today on the heels of receiving U.S. Food and Drug Administration (FDA) 510(k) clearance fo more_horizontal